Skip to main content

Abstract

This chapter discusses the genetics, metabolic actions, substrates, and inhibitors of cytochrome P450 2D6.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhou SF. Polymorphism of human cytochrome P4502D6 and its clinical significance: part 1. Clin Pharmacokinet. 2009;48(11):689–723.

    Article  PubMed  CAS  Google Scholar 

  2. Kosarac B, Fox AA, Collard CD. Effect of genetic factors on opioid action. Curr Opin Anaesthesiol. 2009;22(4):476–82.

    Article  PubMed  Google Scholar 

  3. Sachse C, Brockmöller J, Hildebrand M, et al. Correctness of prediction of the CYP2D6 phenotype confirmed by genotyping 47 intermediate and poor metabolizers of debrisoquine. Pharmacogenetics. 1998;8(2):181–5.

    Article  PubMed  CAS  Google Scholar 

  4. Shen H, He MM, Liu H, et al. Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10 and CYP2D6.17. Drug Metab Dispos. 2007;35(8):1292–300.

    Article  PubMed  CAS  Google Scholar 

  5. Stamer UM, Stüber F. Genetic factors in pain and its treatment. Curr Opin Anaesthesiol. 2007;20(5):478–84.

    Article  PubMed  Google Scholar 

  6. Sohn DR, Shin SG, Park CW, et al. Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations. Br J Clin Pharmacol. 1991;32(4):504–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613–24.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Droll K, Bruce-Mensah K, Otton SV, et al. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians. Pharmacogenetics. 1998;8(4):325–33.

    Article  PubMed  CAS  Google Scholar 

  9. Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth. 2002;89(6):839–45.

    Article  PubMed  CAS  Google Scholar 

  10. Voronov P, Przybylo HJ, Jagannathan N. Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer. Paediatr Anaesth. 2007;17(7):684–7.

    Article  PubMed  Google Scholar 

  11. Madan A, Graham R, Carroll K, et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos. 2003;31:421–31.

    Article  PubMed  CAS  Google Scholar 

  12. Candiotti KA, Birnbach DJ, Lubarsky DA, et al. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? Anesthesiology. 2005;102(3):543–9.

    Article  PubMed  CAS  Google Scholar 

  13. Janicki PK. Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Med Sci Monit. 2005;11(10):RA322–8.

    PubMed  CAS  Google Scholar 

  14. Wink J, Veering BT, Kruit M, et al. The effect of a long term epidural infusion of ropivacaine on CYP2D6 activity. Anesth Analg. 2008;106(1):143–6.

    Article  PubMed  CAS  Google Scholar 

  15. Lantz MS, Buchalter EN, Giambanco V. Serotonin syndrome following the administration of tramadol with paroxetine. Int J Geriatr Psychiatry. 1998;13(5):343–5.

    Article  PubMed  CAS  Google Scholar 

  16. Bartelink IH, Rademaker CM, Schobben AF, et al. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet. 2006;45(11):1077–97.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John C. Sanders MBBS, FRCA .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sanders, J.C., Koll, R., Dull, R.O. (2015). CYP2D6: Where It All Began. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_5

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics